Freedom Meditech raises $4.8M

What does Freedom Meditech do?

Freedom Meditech, is a medical device company which is changing the diagnosis and monitoring of chronic diseases from the present blood based standards to early and non-invasive detection. It provides alternatives to existing diagnostic tools for the detecting, monitoring and managing chronic diseases. It is a private, growth stage medical device company which focuses on the development and commercialization of first to market, non-invasive, ophthalmic medical devices for detecting chronic diseases and managing diabetes. The hallmark feature of their company is to provide free and healthy alternatives to existing diagnostic tools in the market for detecting, monitoring and managing chronic diseases.

How much Freedom Meditech was funded?

Freedom Meditech raised $4.8M in Series C funding on May 28^th, 2015.

Previous funding

$280k in Seed funding on April 28, 2009 from JumpStart Inc.

$630k in Venture round on May 15, 2009

$2M in Series A funding on September 28, 2012 from Silicon Valley Bank

$7M in Series B funding on August 6, 2013

What is next for Freedom Meditech?

The company plans to raiseextra capital and has raised a total of $14 M since founded. Mr.John Gerace was appointed as CEO and a member of the  Freedom Meditech’s  board of directors. He is to oversee all the operations of the company, build the management team and lead the fundraising efforts of the company for expansion of commercialization of the ClearPath DS-120, which is an FDA cleared non invasive tool used by diabetologists, eye care professionals and health care professionals for measuring autofluorescence in the eye. Many independent peer reviewed studies have suggested that the elevated autofluorescence might be an early indicator of presence of diabetes.

More about Freedom Meditech

Freedom Meditech was founded in 2006 by Craig H. Misrach. It has its headquarters in San Diego, CA.